Skip to content
Trial Agents

Institut Gustave Roussy

Institut Gustave Roussy is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

2distinct trials
6recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 2 of 2 trials · Latest update first

International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine

Sponsor GPOH gGmbH

Start (EU)
Latest update
Estimated end
Not reported

Questions about this trial experience

What services are recorded for Institut Gustave Roussy?

The 2026-10-09 snapshot links Institut Gustave Roussy to 2 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, National Coordinating Center France, Project management, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Institut Gustave Roussy?

The most frequently recorded therapeutic areas are Haematological Malignancies. Study-phase tags are not recorded. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Institut Gustave Roussy conducted?

The linked trials record locations in 10 countries, including Germany, France, Netherlands, Sweden, Austria. These are trial locations, not confirmed office locations or countries where Institut Gustave Roussy delivered services.

What can this page tell me about Institut Gustave Roussy's trial experience?

Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Institut Gustave Roussy. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Institut Gustave Roussy

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.